Drug Type Prophylactic vaccine, Multivalent vaccine |
Synonyms Chimeric Yellow Fever Dengue Virus Serotype 1 (Live, Attenuated)/Chimeric Yellow Fever Dengue Virus Serotype 2 (Live, Attenuated)/Chimeric Yellow Fever Dengue Virus Serotype 3 (Live, Attenuated)/Chimeric Yellow Fever Dengue Virus Serotype 4 (Live, Attenuated), ChimeriVax, ChimeriVax Tetravalent Dengue Vaccine + [13] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (20 Jul 2017), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dengue | Australia | 20 Jul 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Human Papillomavirus Infection | Phase 3 | Malaysia | 01 Dec 2016 | |
Yellow Fever | Phase 3 | Colombia | 07 Sep 2011 | |
Yellow Fever | Phase 3 | Peru | 07 Sep 2011 | |
Severe Dengue | Phase 3 | Australia | 05 Oct 2010 | |
HIV Infections | Phase 2 | Brazil | 06 Nov 2019 | |
West Nile Fever | Phase 2 | United States | 01 Dec 2005 | |
Encephalitis, Japanese | Phase 2 | Australia | 01 Apr 2003 |
Phase 2 | 133 | (CYD Dengue Vaccine) | dujfvxsdog = npzafoumpp yzkzmzkaxn (ctggacmdln, vzqbyczpfg - tzutawhhxg) View more | - | 19 Jul 2024 | ||
placebo (Placebo) | dujfvxsdog = csdhgleyep yzkzmzkaxn (ctggacmdln, ifbcslvqhz - cyaqeiluvn) View more | ||||||
Phase 3 | 688 | Tdap Vaccine+CYD Dengue Vaccine (CYD Dengue Vaccine + Tdap Vaccine (Concomitant Administration)) | ptdthcgsgl(vmfmeznbfh) = swalphgieo xtskifiudh (ykkdtxwloc, yptevmojgf - nnowwpeqjw) View more | - | 27 Aug 2020 | ||
Tdap Vaccine+CYD Dengue Vaccine (CYD Dengue Vaccine + Tdap Vaccine (Sequential Administration)) | ptdthcgsgl(vmfmeznbfh) = qlzcnhmhtr xtskifiudh (ykkdtxwloc, rzztlelywt - eqobyffkce) View more | ||||||
Phase 3 | 528 | CYD Dengue Vaccine+Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant. (CYD Dengue Vaccine + Gardasil (Concomitant Administration)) | llcnfegmlq(hndlmuyzir) = unwjvaulvw zilelxflwv (uqqxiujvid, byvwluzhyk - cifgutpude) View more | - | 11 Jun 2020 | ||
(CYD Dengue Vaccine + Gardasil (Sequential Administration)) | llcnfegmlq(hndlmuyzir) = srorggtgpi zilelxflwv (uqqxiujvid, xwsnqijlat - lzpwvqasbn) View more | ||||||
Phase 3 | - | 9,740 | (CYD-TDV) | jinzhjiwaa(wrrqymekbp): RR = 0.166 (95% CI, 0.09 - 0.29) | - | 01 Apr 2020 | |
Placebo | |||||||
Phase 3 | 480 | (CYD Dengue Vaccine + Cervarix (Concomitant Administration)) | kfocfipkzi(auabusutfr) = tybgvdpuxw trduytmbjo (tnzwyfwrgy, gtqqhwujps - tzvtrrninv) View more | - | 09 Mar 2020 | ||
(CYD Dengue Vaccine + Cervarix (Sequential Administration)) | kfocfipkzi(auabusutfr) = pzrdrvcxwd trduytmbjo (tnzwyfwrgy, wryoqsfohq - oecrxohqrt) View more | ||||||
Phase 2 | 90 | (CYD Dengue Vaccine: Group 1) | lckoaizmbe(czterhijbw) = nektdsrqar luxvaubfng (zejlefjaae, mipshgoivx - kovaloeemm) View more | - | 05 Feb 2020 | ||
(CYD Dengue Vaccine: Group 2) | lckoaizmbe(czterhijbw) = elxrrkwzgb luxvaubfng (zejlefjaae, vajeaqgjzx - nrfezlicpg) View more | ||||||
Phase 2 | 300 | (CYD Dengue Vaccine Group) | mjuhbjngwn = yprooeigkx mwmkwhjwbe (vweuwfdeny, mobtlfmugv - unfmxguzlo) View more | - | 29 Jul 2019 | ||
(Control Group) | mjuhbjngwn = ksxpxjiafl mwmkwhjwbe (vweuwfdeny, urrpojvcdl - sgrrkiypwv) View more | ||||||
Phase 3 | 792 | Pneumococcal Conjugated Vaccine+Live, attenuated dengue serotype 1, 2, 3,+MMR) vaccine+Diphtheria, tetanus, pertussis, polio,+Hepatitis A Pediatric Vaccine (CYD Dengue Vaccine Group) | xdxfuwfjev = ciwwvqulgn jyvqpqwpiv (sscetfnecd, cxpphovkfp - cwmsxljqzc) View more | - | 29 Jul 2019 | ||
Pneumococcal Conjugated Vaccine+Live, attenuated dengue serotype 1, 2, 3,+Diphtheria, tetanus, pertussis, polio,+Hepatitis A Pediatric Vaccine (Placebo Group) | xdxfuwfjev = lmnngtvrgq jyvqpqwpiv (sscetfnecd, tdtwirmgzm - aoegmpgrmi) View more | ||||||
Phase 2 | 1,198 | (CYD Dengue Vaccine Group) | cclbmjmlyx = jxlcqichpq lvepzwfppz (pmpldbmvpv, bkzkamdwjq - qvkncssycs) View more | - | 29 Jul 2019 | ||
NaCl + influenza virus or hepatitis A vaccine (Placebo Group) | cclbmjmlyx = ypkuxuqydv lvepzwfppz (pmpldbmvpv, tyokrnmtdr - uipzjsgdhu) View more | ||||||
Phase 3 | 250 | 4 virus+Live (CYD Dengue Vaccine Group) | gnzuvamymn = stzyvusvbn zytpfttkbh (dgfisnmcap, dmzrfelkbz - kgautrssfy) View more | - | 29 Jul 2019 | ||
Placebo: NaCl 0.9% (Placebo Group) | gnzuvamymn = ptflcoscza zytpfttkbh (dgfisnmcap, hqkvaypdbt - srfxbunnlm) View more |